Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.900
+0.080 (2.84%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Cellectis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 75.11 | 79.59 | 49.22 | 9.19 | 25.72 | 38.6 | |
Revenue Growth (YoY) | 37.20% | 61.72% | 435.38% | -64.26% | -33.35% | -35.20% |
Cost of Revenue | - | - | - | 0.74 | 1.77 | 1.84 |
Gross Profit | 75.11 | 79.59 | 49.22 | 8.46 | 23.95 | 36.75 |
Selling, General & Admin | 20.68 | 19.79 | 19.09 | 16.81 | 17.49 | 22.88 |
Research & Development | 98.77 | 93.52 | 90.54 | 87.65 | 97.5 | 117.84 |
Other Operating Expenses | -0.28 | -0.64 | -0.85 | 1.3 | -1.38 | -0.49 |
Total Operating Expenses | 119.18 | 112.67 | 108.77 | 105.76 | 113.62 | 140.23 |
Operating Income | -44.06 | -33.08 | -59.56 | -97.3 | -89.67 | -103.48 |
Interest Income | 22.91 | 16.12 | 44.41 | 21.48 | 8.88 | 13.22 |
Interest Expense | -46.46 | -51.06 | -21.61 | -40.64 | -17.82 | -6.49 |
Total Non-Operating Income (Expense) | -23.54 | -34.94 | 22.79 | -19.16 | -8.94 | 6.73 |
Pretax Income | -67.61 | -68.02 | -36.76 | -116.47 | -98.6 | -96.75 |
Provision for Income Taxes | 0.38 | 0.42 | 0 | -0.37 | -0.09 | - |
Net Income | -49.47 | -67.59 | -36.76 | -108.44 | -114.03 | -125.11 |
Minority Interest in Earnings | - | - | - | -7.38 | -7.89 | -10.91 |
Net Income to Common | -49.47 | -67.59 | -36.76 | -101.06 | -106.14 | -114.2 |
Shares Outstanding (Basic) | 100 | 100 | 91 | 57 | 46 | 45 |
Shares Outstanding (Diluted) | 101 | 100 | 91 | 57 | 46 | 45 |
Shares Change (YoY) | 3.16% | 10.72% | 58.85% | 25.17% | 1.62% | 5.45% |
EPS (Basic) | -0.67 | -0.67 | -0.41 | -1.77 | -2.33 | -2.55 |
EPS (Diluted) | -0.67 | -0.67 | -0.41 | -1.77 | -2.33 | -2.55 |
Free Cash Flow | -39.88 | -41.76 | 20.41 | -25.82 | -89.88 | -123.11 |
Free Cash Flow Per Share | -0.40 | -0.42 | 0.23 | -0.45 | -1.97 | -2.75 |
Gross Margin | 100.00% | 100.00% | 100.00% | 91.98% | 93.11% | 95.22% |
Operating Margin | -58.66% | -41.56% | -121.01% | -1058.44% | -348.57% | -268.11% |
Profit Margin | -65.85% | -84.92% | -74.69% | -1179.63% | -443.30% | -324.14% |
FCF Margin | -53.09% | -52.47% | 41.46% | -280.85% | -349.38% | -318.95% |
EBITDA | -24.4 | -13.01 | -39.71 | -78.78 | -71.23 | -89.33 |
EBITDA Margin | -32.48% | -16.35% | -80.68% | -856.95% | -276.90% | -231.43% |
EBIT | -44.06 | -33.08 | -59.56 | -97.3 | -89.67 | -103.48 |
EBIT Margin | -58.66% | -41.56% | -121.01% | -1058.44% | -348.57% | -268.11% |
Effective Tax Rate | -0.56% | -0.62% | 0.00% | 0.32% | 0.09% | 0.00% |